Dror holds a unique combination of acute scientific expertise and hands-on experience in the commercialization of innovative medical technologies and devices. Considered by many as a leading world-expert in the incorporation of AI into medical-imaging devices.Through RadBee, Dror is engaged in helping life-science companies to transform their innovative technologies into viable products and introduce them to their market. On the R&D front, Dror has hands on experience in formulating methods and protocols for big-data collection and analysis while complying with the latest GDPR and HIPAA regulations. Dror has strong relations with KOLs from leading academic institutions across Europe and the USA as well as with major players in the medical-devices industry. Dror's major career achievement was the successful introduction of a unique and disruptive AI based medical-imaging device, HistoScanning, into the cancer management pathway: After being successfully integrated and received in clinics across Europe, the ultrasound-based device is currently used by urologists to promote and improve the detection rates of prostate cancer. Dror is also an accomplished CEO particularly proficient with start-ups and SME's within the MedTech industry. Having spent the past two decades developing and bringing to market sophisticated, state-of-the-art technologies, Dror is well positioned for assessing the viability and route-to-market of new technologies. His focus over decades in specifically promoting life-sciences ventures has provided him with an in-depth and intimate understanding of the healthcare market and its many particularities and opportunities. Dror received his PhD in Nuclear Physics from Tel-Aviv University, Israel in 1993.